Trials / Completed
CompletedNCT01053832
Ventricular Pace Suppression Study
Ventricular Pace Suppression Study With the EVIA/ENTOVIS DR-T/DR Pacemaker
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Investigation of the efficacy and safety of the Ventricular Pace Suppression (VpS) algorithm.
Detailed description
The aim of this study is to investigate the percentage of reduction of ventricular pacing using the VpS feature of the EVIA/ENTOVIS pacemaker in a controlled clinical investigation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VpS algorithm in EVIA and ENTOVIS pacemakers | For one group of patients, the VpS algorithm will be activated and for the other group, the VpS algorithm will be deactivated until the cross-over, where these conditions will be switched. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2010-01-21
- Last updated
- 2011-10-25
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01053832. Inclusion in this directory is not an endorsement.